James E. Levine
Chief Financial Officer · KAZIA THERAPEUTICS LTD
- 2024
- Jun 23, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James E. Levine files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gary W. Pace - $1.04M in CRDF purchases and sales in the last 12 months
- Mani Mohindru - $80K in CRDF purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James E. Levine?
James E. Levine is a corporate insider, tracked as Chief Financial Officer of KAZIA THERAPEUTICS LTD (KZIA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did James E. Levine last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 2 filings going back to 2024.
Has James E. Levine been buying or selling stock?
Recorded transactions: 3 open-market purchases ($37K) and 0 open-market sales across all tracked filings.
